Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

JAMA Oncol. 2021 Aug 1;7(8):1123-1125. doi: 10.1001/jamaoncol.2021.2096.

Authors

Lova Sun¹, Jeremy L Warner^{2

3}, Ravi B Parikh^{1

4}

Affiliations

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.
³ Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee.
⁴ Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

PMID: 34047766
DOI: 10.1001/jamaoncol.2021.2096

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Humans
Immunity
Neoplasms* / epidemiology
SARS-CoV-2